A B S T R A C T The present study is an attempt to determine (a) if the lung actively secretes protein into the surface-active fraction of lung lavage returns; (b) if there are interspecies differences in this secretory activity; and (c) if the amount of nonradioactive protein in the lavage surface-active fraction shows interspecies variation.
A B S T R A C T The present study is an attempt to determine (a) if the lung actively secretes protein into the surface-active fraction of lung lavage returns; (b) if there are interspecies differences in this secretory activity; and (c) if the amount of nonradioactive protein in the lavage surface-active fraction shows interspecies variation.
I found that pilocarpine stimulates the release of radioactive protein into the lavage surface-active fraction of rabbits and that this pilocarpine effect is completely blocked by atropine. Inhibition of lung oxygen consumption by iodoacetate is associated with a dosedependent inhibition of the pilocarpine-induced secretion. Microtubules may be involved in this secretory process because colchicine inhibits the pilocarpine effect.
Of the radioactive protein in the total surface-active fraction (tissue plus lavage returns), a greater percent appears in the lavage surface-active fraction at 2 and 4 h, after a pulsed injection of [U-'4C]leucine, in the mouse than in the rat, which in turn has a greater amount than the rabbit. There is also a difference in the amount of nonradioactive protein per square meter of alveolar surface area in the lavage surface-active fraction of different species: mouse> rat> rabbit> cat> dog. The amount of nonradioactive protein per square meter of alveolar surface area in the lavage surfaceactive fraction is directly proportional to the species respiratory rate; the log of the nonradioactive protein in the lavage surface-active fraction is inversely proportional to the log of the species alveolar diameter.
INTRODUCTION
Current concepts indicate that the lung is lined by a duplex extracellular layer that contains a lipoprotein (s) (pulmonary surfactant). Because of its surface tensionlowering effect, pulmonary surfactant allows alveoli to remain open at low transpulmonary pressures (1) (2) (3) .
To produce this extracellular layer, lung cells must be able to synthesize and secrete molecules that are components of this extracellular material.
A large body of work has shown that the lung can utilize various substrates, such as glucose, acetate, palmitate, and glycerol, to form phospholipids (4) (5) (6) (7) (8) (9) (10) (11) . Lung slices can incorporate radioactive glucose into glycoproteins (12) and radioactive leucine into protein (13) , and more specifically into protein found in a surfaceactive lung fraction (14) . Thus, it seems clear that lung tissue possesses the ability to synthesize components of pulmonary surfactant.
In addition, studies have provided kinetic evidence for intracellular protein transport in lung (13) and radioautographic work has shown that protein (15, 16) and lipid (16) transport take place in the granular pneumocyte, the cell believed to be the site of synthesis of surfactant. Newly synthesized radioactive protein is released by lung slices, and this release is inhibited by low temperature or cyanide and stimulated by epinephrine, which indicates that this release is an active secretory process (13) . In vivo studies are consistent with a precursor-successor relationship between cellular lipid (17) (18) (19) (20) (21) and protein, including protein in a surfaceactive fraction (22) , and similar fractions obtained by lung lavage.
The present study was undertaken to examine factors that influence the appearance of radioactive protein in a surface-active fraction obtained from lung lavage returns and hence, presumably, from the internal surface of terminal lung units. In particular I wished to examine the influence of a cholinomimetic alkaloid (pilocarpine), its antagonist (atropine), a metabolic inhibitor (iodoacetate), and a disruptor of microtubules (colchicine) on the release of protein into a surface-active fraction obtained by lung lavage. I also wished to determine if there is any difference in the amount of protein in the lavage surface-active fraction per square meter of alveolar surface in animals of different species.
METHODS
Animals. I used male New Zealand albino rabbits (Ginrich Animal Supply, Fredericksburg, Pa.), male LongEvans descent hooded rats (Blue Spruce Farms, Inc., Altamont, N. Y.), male black mice, strain C57BL/6J, (Jackson Laboratories, Bar Harbor, Me.), and mongrel cats and dogs of either sex (Leach Kennels, Chase City, Va.). All were allowed food and water ad libitum. The animals were sacrificed by exsanguination after the i.p. injection of sodium pentobarbital, 50 mg/kg. Before the lungs were removed from the chest, the left atrium was cut and the pulmonary artery perfused with cold 0.15 M NaCl until the lungs appeared bloodless.
Secretion studies in rabbits. These animals weighed 2.7± 0.3 kg (mean±SD). To "pulse-label" lung protein, I injected 0.1 ml of L-[U-"C]leucine (17 X 10-8 Amol of L-['C] leucine in 0.2 ml of saline. 56 min after the ['C]leucine injection, the rabbits were given either 1.0 ml of pilocarpine (3 mg/kg body wt in saline), or saline alone, i.p. This was repeated after an additional 30 min and the rabbits were sacrificed 30 min after this second injection. In some experiments atropine sulfate (4 mg/kg body wt) in 0.1 ml of saline or 0.1 ml of saline alone was immediately given by vein after each injection of pilocarpine. In other experiments I injected colchicine (0.5 mg/kg body wt) in 0.1 ml of saline, or 0.1 ml of saline i.v. 16 h before the pulse-labeling procedure.
After the rabbits were sacrificed and their lungs perfused with cold saline, the lungs were removed intact from the chest, separated from the thoracic contents, and lavaged with cold saline containing 10' M Tris at pH 7.2. In preliminary experiments I lavaged each pair of lungs 10 times with 50 ml of fresh saline each time. After each injection of 50 ml into the clamped trachea, the clamp was removed and the lung emptied by its own recoil and gentle kneading. When the results of these preliminary experiments were known, I performed all rabbit experiments with five lavages of 50 ml each.
After the lung lavages I removed all the large bronchi and vessels and then minced and homogenized the lung in cold saline-Tris solution by 30 passes of a motor-driven Teflon pestle in a glass homogenizing vessel. To obtain the surface-active fraction, the lung homogenate and the lung lavage material were then separately subjected to the isolation procedure previously used (14) , a modification of the method described by Klein and Margolis (23) . Carrier albumin was added to the lavage and tissue surface-active fraction and protein was precipitated with trichloroacetic acid (TCA). The precipitated material was extracted with lipid solvents and hot TCA and assayed for radioactivity as previously described (24, 25) .
To determine the percent distribution of radioactive protein between the lavage and tissue surface-active fractions, I divided the radioactivity in disintegrations per minute in the protein of the lavage surface-active fraction by the combined radioactivity of the lavage and tissue surface-active fractions and multiplied this figure by 100 to convert it to a percentage.
This approach requires that the labeling of the protein in the tissue surface-active fraction occur as a discrete short pulse and that continued incorporation of the label be prevented. To ascertain if this was the case I performed preliminary pulse-labeling experiments as described above; rabbits received an i.v. pulse-chase and rats an i.p. pulse-chase.
The animals were then sacrificed at 0, 60, and 120 min after the injection of the chase of [12C]leucine (n = 3 for rats and rabbits at each time). The protein-specific radioactivity of the surface-active fraction for rats at these times was 440±10, 367±8, and 386±+15, dpm/mg protein; for rabbits the figures are 107±5, 90+10, and 87±7 dpm/mg protein, respectively. These studies show the pulse-labeling procedures are effective because there isn't any rise in the protein-specific radioactivity of the surface-active fraction after the i.v. or i.p. injection of nonradioactive leucine.
Since pilocarpine stimulates secretion by tracheobronchial glands (26) , I sought to examine the possibility that radioactive material secreted by tracheobronchial mucus glands might have contaminated the surface-active fraction. I therefore pulse-labeled rabbits with radioactive leucine, gave them pilocarpine as described above, and then sacrificed 'them. I ligated the right and left main bronchi and lavaged the trachea and main bronchi with the same volume of saline used to lavage the entire lung in the intact lung experiments. This tracheal lavage material from the pilocarpine-treated radioactive rabbits was thoroughly mixed with the surface-active fraction isolated from nonradioactive rabbit lungs. I then reisolated the surface-active fraction and assayed it for radioactive material that was insoluble in cold and hot TCA and in lipid solvents (14) . I failed to detect any radioactivity by the same assay procedure I used for the secretory studies.
To determine if the pilocarpine-induced apparent increase in secretion by the lung might in fact have been due to a higher protein specific activity of blood proteins, I measured the influence of pilocarpine on the protein specific activity of blood. To do this I pulse-labeled six rabbits with ["C] leucine. Half of these rabbits received pilocarpine, as described above, and the other three received only saline. I withdrew venous blood from the rabbits at 0, 60, and 120 min after the pulse-labeling and assayed it for its protein specific radioactivity (24) . The protein specific activity of blood from control rabbits at these times was 8±1, 14±3, and 18±5 dpm/mg protein (mean±lSEM); the values for pilocarpine treated rabbits are 7±2, 15+4, and 17+3 dpm/mg protein.
Finally, in an attempt to examine the influence of pilorabbits untreated with pilocarpine. The surface-active fraction, I injected rabbits with radioactive leucine, as described above, but did not follow with an injection of non-radioactive leucine. The animals (n = 3) were sacrificed after 1 h and the surface-active fraction isolated. This was divided into samples of known protein radioactivity, which were then mixed with lung homogenates and lung lavage returns from three nonradioactive pilocarpine-treated rabbits and three rabbits untreated with pilocarpine. The surface-active fraction was then isolated from these lavage returns and homogenates and assayed for protein radioactivity. The recovery from the lavage returns were 92±3% (mean±lSEM) and 90±4% for control and pilocarpine-injected rabbits, and 85+5% and 87+7% for the homogenates of control and pilocarpine-treated rabbits, respectively.
Time course studies on radioactive protein secretion in rabbits, rats, and mice. These experiments involved a pulse-labeling procedure but not agents to stimulate or inhibit secretion. Rabbits were given a pulse of radioactive leucine and their lungs were lavaged as described above. The rabbit lungs were lavaged as described. The rat lungs were lavaged five times with 5 ml of cold saline containing 10' M Tris at pH 7.2 for each lavage. Mouse lungs were lavaged five times with 0.5 ml of this lavage solution for each lavage. After each lavage the trachea was unclamped and the lung emptied by its own recoil and gentle kneading. The lungs and lavage returns were then treated as described for rabbits to isolate the surface-active fractions and to assay their protein radioactivity. In this part of the study the animal weights (mean±SD) were: rabbits 2.7+0.2 kg, rats 0.305±0.04 kg, mice 0.025+0.002 kg.
Lung lavage for nonradioactive protein. For these experiments we used mice, rats, rabbits, cats, and dogs. In the mice, rats, and rabbits, lung lavage was performed as described. In dogs and cats, the lungs were inflated with enough lavage fluid to smoothly inflate all areas. This volume of solution was then used for four additional lavages with fresh solution each time. In those experiments with the dogs and cats where I wished to determine the percent of protein in the total surface-active fraction (lavage plus tissue) in the lavage returns, I lavaged a lobe and homogenized and isolated the tissue surface-active fraction from that lobe. To determine the percent distribution of nonradioactive protein between the lavage and tissue surface-active fractions, I divided the amount of protein in the lavage surfaceactive fraction by the amount of protein in the lavage and tissue surface-active fraction and multiplied the quotient by 100 to convert it to a percentage.
In those experiments where I wished to compare the amount of protein in the lavage surface-active fraction to the species alveolar surface area, I lavaged the entire dog or cat lung but did not make any measurements of the tissue surface-active fraction. The lavage returns were collected and the surface-active fraction was isolated from the lavage returns as described above. In this section of the study, protein was measured directly on the surface-active fraction without the addition of carrier albumin and without the acid precipitation steps. I used crystallized albumin (Mann Research Laboratories Inc., New York) as the standard for the assay (27 (29) .
RESULTS
Influence of experimental conditions on the recovery of protein and fluid from lung lavage returns. In all species studied in preliminary experiments (rabbit, rat, mouse, cat, and dog), slightly more than 90% of the protein in the surface-active fraction recovered after 10 separate lavages is found in the first three lavage returns. I therefore used five ravages in all experiments in all species studied. The various experimental conditions used in the rabbit experiments did not influence the volume of fluid recovered after five separate lavages. Thus in saline (n = 6), pilocarpine (n = 4), pilocarpine plus atropine (n = 3), colchicine plus pilocarpine (n = 4), and iodoacetate plus pilocarpine (n = 6), after five separate lavages of 50 ml each, the volume recovered was 90.6±1.4% (mean±SEM), 89.1+4.8%, 83.4+5.7%, 93.5±1.5%, and 81.9±4.9%, respectively. In experiments where five separate lavages were performed the volume recovered in different species, as a percent of the volume injected, was mouse (n = 4) 52±2% (mean+ SEM), rat (n = 18) 82.3±1.1%, rabbit (n = 38) 88.7±1.0%, cat (n = 6) 95.3±2.9%, and dog (n =6) 89.0±3.6%. There is very little difference in the volume of lavage fluid recovered from different species except for the mouse. I think the low recovery from the mouse may have been caused by the difficulty experienced in working with the small mouse trachea.
Stimulation and inhibition of protein secretion. Pilocarpine produced a 2. (Fig. 1) . Since pilocarpine stimulates sec tracheobronchial mucus glands (26) , it is pos radioactive material from this source could cot our surface-active fraction. I think this is unl cause I failed to detect any radioactivity when nonradioactive surface-active fractions with used to lavage only the trachea and mainsten isolated from rabbits given a pulse of radioa( cine, and then reisolated the surface-active fray assayed it for radioactivity.
Atropine completely blocks the effect of pi (Fig. 1) . Colchicine, which inhibits protein in other organs (30) (31) (32) produces a significa 0.005) inhibition of the pilocarpine effect (Fij determine if the agents studied might exert fluence on secretion by altering the lung's Q amined the latter and found it is not influenced time studied by pilocarpine, pilocarpine plus or colchicine (Table I) .
Influence of inhibition of metabolism on pi] induced secretion. To determine if the piloca fect required active lung metabolism, I exar response to pilocarpine in animals whose lung impaired. I administered iodoacetate to rabbits and then measured the Qo2 of lung slices. I found a dosedependent decrease in lung oxygen consumption that persisted over the 2 h of the study (Fig. 2a) . Iodoacetate also produced a dose-dependent decrease in the percentage of radioactive protein in the lavage surfaceactive fraction after administration of pilocarpine (Fig.   *   2b) .
Species influence on secretion and on the amount of protein in the ravage surface-active fraction. The appearance of radioactive protein in the lavage surfaceactive fraction varies between species. At each time studied I found a greater percent of the radioactive protein in the surface-active fraction in the lavage material in the mouse than the rat; the rat has a greater percent in the lavage surface-active fraction than the rabbit (Fig. 3). '......... (Fig. 4a) (33) . The (Fig. 4b) . The log of the protein Xsents one in the lavage surface-active fraction varies inversely mean.
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tive frac-The values for respiratory rate (34) (Fig. 5a) ; there is an inverse solutions relation with the species alveolar diameter (Fig. 5b) .
i bronchi ctive leu-.ction and Saline (9) 150.4±4.1
Pilocarpine (4) 141.246.0
Pilocarpine and atropine (4) 142.3 ±5.6 Colchicine (4) 153.5±11.3
All rabbits were given these agents, as described in Fig. 1 . 
DISCUSSION
Studies on a wide variety of tissues have defined the characteristics of cell systems that secrete protein (36) . In general these exhibit the following features: (a) they respond to certain chemicals or hormones, such as various cholinergic agents, with an increase in secretion; (b) energy, usually derived from oxidative metabolism, is essential for secretion, as evidenced by a decrease in the secretory response to a stimulant when metabolism is inhibited; (c) the secreted molecules are derived directly from intracellular storage granules. The present work and other recently reported biochemical and ultrastructural studies provide evidence that the intact lung meets these criteria. I have shown that the administration of pilocarpine, a cholinergic agent, results in an increase in the relative amount of radioactive protein in the surface-active fraction of the alveolar compartment and that this response can be blocked by atropine. Pilocarpine and atropine have a similar effect on phospholipid secretion (37, 38) . In addition, blocking this pilocarpine effect with iodoacetate, which inhibits lung oxygen consumption, indicates that the stimulatory effect of pilocarpine is influenced by the level of the lung's oxidative metabolism. Evidence that the secreted proteins and phospholipids are derived directly from intracellular storage granules is less direct. Goldenberg, Buckingham, and Sommers concluded from nonquantitative morphological observations, that pilocarpine stimulates secretion of lamellar body contents into the alveolar lumen (39). This conclusion received support from recent stereological studies that report that after pilocarpine administration there is a decrease in the volume density of lamellar bodies per granular pneumocyte profile; atropine blocks this response (37) . These morphological studies and the evidence that lamellar bodies are rich in phospholipid and contain protein (40) support the concept that the secreted phospholipids and proteins are derived, at least in part, from the intracellular storage granules that the lamellar bodies are considered to represent.
Microtubules and microfilaments are thought to play a role in the secretion of proteins from various tissues (30) (31) (32) . This concept is based on the finding that agents such as colchicine and vinblastine, which interrupt the structural integrity of microtubules, also inhibit the secretion of various proteins. The response associated with the administration of colchicine suggests that protein secretion in the surface-active fraction is dependent on the integrity of microtubules.
The present study and those reported by others (37) (38) (39) I (3) j (4) I (4) { (6) 1 (6) 2 HOURS 4 FIGURE 3 Species differences in the secretion of radioactive protein into the lavage surface-active fraction. The pulselabeling procedures were as described in the legend of Fig. 1 These findings suggest that there might be two inseries replacement mechanisms for the ventilatory-induced depletion of alveolar film surface-active material. The first mechanism, a physical effect, would relate to a greater rate of adsorption of surface-active material into the lining film from the hypophase of the duplex lining layer. This might relate to a greater amount of protein in the hypophase which, in vitro, seems to accelerate adsorption of surface-active material (42), or to an excess of both lipid and protein. Breath-by-breath replacement of surface-active material in the surface film, more rapidly needed in species with high respiratory rates, would occur from this source. The second replacement mechanism, also related to respiratory rate, would be secretion of surface-active material into the hypophase. Because the secretion of molecules from storage granules is a bulk affair, I view this second mechanism, as incapable of the fine control that breath-by-breath adjustments would require.
The means by which respiratory rate might be coupled to neurohumoral-mediated secretion is unclear. This could be achieved by the presence in the alveolar wall of nerve endings sensitive to changes in pressure or distention. This potential mechanism has some basis in recent anatomical findings. Hung, Hertweck, Hardy, and Loosli found two types of nerve endings in close association with alveolar epithelial cells (43) . One type, located in the alveolar epithelial cells, has anatomical features similar to sensory fibers in other organs (44, 45) and similar to the "type J" receptors considered to respond to changes in pulmonary interstitial pressure (46) . The other type of nerve ending in the alveolus is found in close association with the granular pneumocyte, and, because of its anatomical similarity to nerves in endocrine organs, may have a motor function (47 
